Effects of transcutaneous auricular vagus nerve stimulation on postoperative pulmonary complications and early recovery quality in elderly patients undergoing thoracoscopic pulmonary resection
ObjectiveTo investigate the effects of transcutaneous auricular vagus nerve stimulation (taVNS) on the incidence of postoperative pulmonary complications (PPCs) and early recovery quality in elderly patients undergoing elective thoracoscopic pulmonary resection.MethodsA total of 150 elderly patients scheduled for elective thoracoscopic pulmonary resection were randomly divided into two groups, with 75 patients in the taVNS group and 75 patients in the sham stimulation group. The taVNS group received 30 min of continuous taVNS stimulation at three time points: 1 day before surgery, before anesthesia induction, and 1 day after surgery. The sham stimulation group received sham stimulation at the identical time points. Outcome indicators were recorded, including the occurrence of PPCs within 7 days after surgery or before discharge, the 15-item quality of recovery (QoR-15) scores on postoperative day 1 and day 2, numerical rating scale (NRS) pain scores after extubation as well as on postoperative day 1 and day 2, plasma inflammatory biomarkers on postoperative day 1, the number of rescue analgesia administrations, and postoperative hospital stay.ResultsCompared with the sham stimulation group, the taVNS group exhibited significantly lower overall incidence of PPCs and incidence of pleural effusion within 7 days postoperatively or before discharge (P<0.05, P<0.01). On postoperative day 1, the QoR-15 score was markedly higher in the taVNS group (P<0.05), while the NRS score was significantly lower (P<0.05). Moreover, the number of rescue analgesia times (P<0.05) and plasma C-reactive protein level on postoperative day 1 (P<0.01) were reduced in the taVNS group. Multivariate Logistic regression analysis revealed that taVNS was an independent protective factor against PPCs (OR = 0.36, 95%CI: 0.14–0.92, P<0.05).ConclusiontaVNS can significantly reduce the incidence of PPCs, alleviate inflammatory response and postoperative pain, and improve early recovery quality in elderly patients receiving thoracoscopic pulmonary resection.